2024
DOI: 10.1007/s00232-023-00302-z
| |Summarize |Cite
|
Sign up to set email alerts

Lidocaine Inhibits Rat Prostate Cancer Cell Invasiveness and Voltage-Gated Sodium Channel Expression in Plasma Membrane

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
0
0

Citation Types

1
3
0
0

Year Published

Range
2025
2025
2026
2026

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

Cited by 4 publications

(4 citation statements)

References 41 publications

1
3
0
0
Order By: Relevance
How the paper below cites the one you are viewing
“…This was a true effect on invasion because, at the working concentration of tetracaine, neither proliferation nor cell viability were involved. These findings agree with previous work on multiple cancer types (especially breast, colon and prostate cancers) showing (i) that VGSC activity promotes metastatic cell behaviours and (ii) that local anaesthetics can block invasiveness [ 13 , 14 , 15 ]. On breast cancer MDA‐MB‐231 cells, for example, tetracaine had a significant suppressive effect on motility, invasion and adhesion [ 11 ].…”
Section: Discussion
supporting
confidence: 92%
“…In addition to tetracaine, several clinically approved VGSC modulators, originally developed for non‐oncological indications, have gained increasing attention for their potential anticancer properties. In particular, lidocaine, a widely used local anaesthetic, and ranolazine, an antianginal agent, have both demonstrated inhibitory effects on cancer cell proliferation, migration and invasion in preclinical including human studies [ 15 , 17 ]. Furthermore, human trials suggested that perioperative administration of lidocaine can be associated with reduced cancer recurrence rates and longer patient survival [ 18 ] Another interesting candidate is ranolazine, which (i) binds to the same site intracellular site within the VGSC protein as local anaesthetics and (ii) blocks selectively the channel's persistent current leading to inhibition of metastasis with real‐world evidence suggesting a survival benefit [ 17 ].…”
Section: Discussion
mentioning
confidence: 99%
See 1 more Smart Citation